# Genoimmune

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/genoimmune

- Industry: Biotechnology
- Headquarters: Wuhan, China
- Website: http://genoimmune.genomics.cn
- Total disclosed funding: $33M
- Latest round: Series A (Dec 8, 2020)
- Investors on record: 3

## About

Established in 2017 and based in Wuhan, China, Genoimmune operates as a cancer therapy developer that focuses on the research of tumor genomics, bioinformatics and tumor immunity.

## Funding rounds

- Series A, Dec 8, 2020, $15M — East Lake Ventures, GL Ventures
- Series A, Mar 20, 2019, $18M — GF Xinde Investment

## Investors

- GF Xinde Investment (https://capitalatlas.ai/funds/gf-xinde-investment) — Series A
- East Lake Ventures (https://capitalatlas.ai/funds/east-lake-ventures) — Series A
- GL Ventures (https://capitalatlas.ai/funds/gl-ventures) — Series A